Malignant PNST in humans often develops subsequent to neurofibromatosis type I in which inactivation of the NF1 tumor suppressor gene (TSG) results in activation of the MAP kinase signaling pathway31. The gene discussed is NF1; the disease is neurofibromatosis type 1.